Global Asthma Management Products Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Asthma Management Products Market Research Report 2024
Asthma is a chronic disease, which cannot be cured only appropriate management is possible to control the disease. Asthma targets airways of the lungs causing it to inflame, swallow and tightens the airway of the lungs, causing respiratory tract infection and causing symptoms such as coughing, shortness of breath, tightness, and wheezing. The symptoms of the asthma are related to physical activity, even healthy people suffer from asthma symptoms during vigorous exercise. This type of asthma is called exercise-induced bronchoconstriction (EIB). This type of asthma is controlled and the symptoms are kept under control by developing a management plan by a physician. People with family history of asthma are more prone to this illness and develop allergies frequently. This type of asthma is called allergic asthma. The allergies/asthma due to toxic fumes, gases, dust during the occupation/work in known as occupational asthma. Childhood asthma effects millions of children and is developed in mainly during first five years of life.
According to Mr Accuracy reports’s new survey, global Asthma Management Products market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Asthma Management Products market research.
Asthma is diagnosed by looking after patient medical history and performing breathing tests, this test helps to measure the amount of air the lungs can hold and examines asthma severity. The medication to manage asthma symptoms are taken daily and contains inhaled corticosteroids such as ciclesonide, budesonide, flunisolide and others. Short acting beta agonist are prescribed for quick relief. The inhaler contains beta blockers and inhaled corticosteroid. Leukotriene modifiers are prescribed for asthma as oral medication. The people suffering from symptoms suffer from respiratory infections such as influenza and pneumonia.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Asthma Management Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Teva Pharmaceutical Industries
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
GE Healthcare
Merck
Baxter
GlaxoSmithKline
Sanofi-Aventis
Novartis
Segment by Type
Corticosteroids
Bronchodilators
Others
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Online Pharmacy
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Asthma Management Products report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Asthma Management Products market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Asthma Management Products market research.
Asthma is diagnosed by looking after patient medical history and performing breathing tests, this test helps to measure the amount of air the lungs can hold and examines asthma severity. The medication to manage asthma symptoms are taken daily and contains inhaled corticosteroids such as ciclesonide, budesonide, flunisolide and others. Short acting beta agonist are prescribed for quick relief. The inhaler contains beta blockers and inhaled corticosteroid. Leukotriene modifiers are prescribed for asthma as oral medication. The people suffering from symptoms suffer from respiratory infections such as influenza and pneumonia.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Asthma Management Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Teva Pharmaceutical Industries
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
GE Healthcare
Merck
Baxter
GlaxoSmithKline
Sanofi-Aventis
Novartis
Segment by Type
Corticosteroids
Bronchodilators
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Online Pharmacy
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Asthma Management Products report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices